Strategic Partnerships Leverage existing distributor relationships and healthcare networks (Thermo Fisher/Fisher Healthcare, McKesson, Johnson & Johnson Innovation, Novartis Venture Fund) to expand reach of binx io in clinics, retail, and home settings.

Retail Reach Expansion Target collaboration with retail clinics, supermarkets, and primary care offices to deploy rapid 24-plex PCR testing, positioning binx as a convenient, on-demand testing solution integrated with point-of-care workflows.

Home and Primary Care Focus Capitalize on consumer mobile offerings and at-home testing assets to upsell bundled testing services, telehealth tie-ins, and subscription models for periodic screening in underserved or high-traffic consumer touchpoints.

Regulatory Ready Highlight FDA-cleared CLIA-waived status of binx io to accelerate conversations with retailers, clinics, and payers seeking compliant, scalable point-of-care molecular testing solutions.

Financial Trail Leverage current funding and revenue trajectory to pursue joint ventures or co-development deals with strategic investors, aiming to broaden test menu, increase scale, and improve unit economics.